Peter Lynch Detailed Fundamental Analysis

Validea's guru fundamental report indicates BECTON DICKINSON AND CO (BDX) rates highest among its tracked strategies using the Peter Lynch P/E/Growth Investor model, achieving a 50% score based on its fundamentals and valuation. While the model seeks reasonable pricing relative to earnings growth and strong balance sheets, this 50% rating falls below the 80% threshold for general investment interest, despite BDX passing criteria like P/E/Growth ratio and total debt/equity, yet failing on sales and P/E ratio and EPS growth rate.

Analysis

According to a Validea fundamental report, Becton, Dickinson and Co. (BDX) presents a mixed profile under the Peter Lynch P/E/Growth Investor model, achieving a score of only 50%. This rating is significantly below the 80% threshold that Validea considers indicative of investment interest. The analysis reveals a dichotomy in the company's fundamentals: BDX passes on its P/E/Growth ratio, inventory-to-sales management, and total debt-to-equity ratio, suggesting a reasonably managed balance sheet and some valuation appeal. However, these strengths are directly countered by critical failures in its EPS growth rate and its sales-to-P/E ratio. The lack of earnings growth is a particularly significant weakness for a model that prioritizes growth at a reasonable price. Furthermore, neutral ratings for free cash flow and net cash position fail to provide any additional positive catalysts, cementing the stock's mediocre standing within this specific quantitative framework.

Key Decisions for Investors

• Given the 50% score is well below the 80% interest threshold and the failure on the critical EPS growth rate metric, investors should not interpret this model's 'highest rating' as a bullish signal for BDX.
• Investors should closely scrutinize BDX's upcoming earnings reports for any acceleration in the EPS growth rate, as the current weakness is a primary factor undermining its investment case according to this growth-focused strategy.
• The conflicting signals—passing on balance sheet health (debt/equity) but failing on growth (EPS) and valuation (sales/P/E)—suggests that a deeper, independent analysis is required before committing capital, as the stock does not cleanly fit the growth-at-a-reasonable-price profile.